Low-dose neuroleptic therapy and extrapyramidal side effects in schizophrenia: An effect size analysis

European Psychiatry

Volumn 11, Issue 8, 1996, Pages 412-415

  Barbui, C ^a   Saraceno, B ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Low dose; Neuroleptic; Side effects

Indexed keywords

NEUROLEPTIC AGENT;

ARTICLE; DRUG DOSE; EXTRAPYRAMIDAL SYNDROME; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0030462341     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-9338(97)82580-1     Document Type: Article

References (24)

1. Baldessarini RJ, Cohen BM, Teicher M. Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses. Arch Gen Psychiatry 1988;45:79-91
2. Bangert-Drowns RL. Review of developments in meta-analytic method. Psychol Bull 1986;99:388-99
3. Barber JP, Luborsky LB. Psychotherapy research: issues to consider in planning a study. In: Hsu LKJ, Hersen M, eds. Research in Psychiatry. Issues, Strategies and Methods. New York: Plenum, 1992;331-58
4. Barbui C. Terapia a lungo termine delle psicosi: neurolettici ed interventi psicosociali. Lett Perc Bibliogr Psichiat 1995;XIX:1-36
5. Barbui C, Saraceno B, Liberati A, Garattini S. Low-dose neuroleptic therapy and relapse in schizophrenia: meta-analysis of randomized controlled trials. Eur Psychiatry (in press)
6. Bollini P, Pampallano S, Orza MJ, Adams ME, Chalmers TC. Antipsychotic drugs: is more worse? A meta-analysis of the published randomized controlled trials. Psychol med 1994;24:307-16
7. Burnett PL, Galletly CA, Moyle R, Clark CR. Low-dose depot medication in schizophrenia. Schizophren Bull 1993;19: 155-64
8. Cohen J. Statistical Power Analysis for the Social Sciences, 2nd edn. New York: Academic Press, 1977
9. Gilbert PL, Harris MJ, McAdams LA, Jeste DV. Neuroleptic withdrawal in schizophrenic patients. A review of the literature. Arch Gen Psychiatry 1995;52:173-88
10. Hasselblad V, Mosteller F, Littenberg B et al. A survey of current problems in meta-analysis. Med Care 1995;33:202-20
11. Hogarty GE, McEvoy JP, Munetz M et al. Dose of fluphenazine, familial expressed emotion, and outcome in schizophrenia. Arch Gen Psychiatry 1988;45:797-805
12. Inderbitzin LB, Lewine RRJ, Scheller-Gilkey G et al. A double-blind dose-reduction trial of fluphenazine decanoate for chronic, unstable schizophrenic patients. Am J Psychiatry 1994;151:1753-9
13. Johnson DAW, Ludlow JM, Street K, Taylor RDW. Double-blind comparison of half-dose and standard-dose flupenthixol decanoate in the maintenance treatment of stabilized out-patients with schizophrenia. Br J Psychiatry 1987;151:634-8
14. Kane JM, Rifkin A, Woerner M, Reardon G, Sarantakos S, Schiebel D, Ramos-Lorenzi J. Low-dose neuroleptic treatment of outpatient schizophrenics. Arch Gen Psychiatry 1983;40:893-6
15. Marder SR, Van Putten T, Mintz J et al. Costs and benefits of two doses of fluphenazine. Arch Gen Psychiatry 1984; 41:1025-9
16. Marder SR, Van Putten T, Mintz J, Lebell M, McKenzie J, May PRA. Low-and conventional-dose maintenance therapy with fluphenazine decanoate. Arch Gen Psychiatry 1987;44:518-21
17. Morgenstern H, Glazer WM, Niedzwiecki D, Nourjah P. The impact of neuroleptic medication on tardive diskinesia: a meta-analysis of published studies. Am J Publ Health 1987;77:717-24
18. Rosenthal R, Rubin DB. Comparing effect sizes of independent studies. Psychol Bull 1982;92:500-4
19. Saraceno B. Los psicofármacos en una perspectiva de salud pública. Acta Psiquiát Psicol Am Lat 1993;40:63-8
20. Schooler NR. Maintenance medication for schizophrenia: strategies for dose reduction. Schizophren Bull 1991;17: 311-24
21. Schooler NR. Reducing dosage in maintenance treatment of schizophrenia. Br J Psychiatry 1993;163(suppl 22):58-65
22. Streiner DL. Using meta-analysis in psychiatric research. Can J Psychiatry 1991;36:357-62
23. Thacker SB. Meta-analysis. A quantitative approach to research integration. J Am Med Assoc 1988;259:1685-9
24. Wyatt R. Neuroleptics and the natural course of schizophrenia. Schizophren Bull 1991;17:325-51